Effectiveness of Artificial Intelligence Technologies in Cancer Treatment for Older Adults: A Systematic Review.
Doris C ObimbaCharlene EstevaEurika N Nzouatcham TsicheuRoger WongPublished in: Journal of clinical medicine (2024)
Background: Aging is a multifaceted process that may lead to an increased risk of developing cancer. Artificial intelligence (AI) applications in clinical cancer research may optimize cancer treatments, improve patient care, and minimize risks, prompting AI to receive high levels of attention in clinical medicine. This systematic review aims to synthesize current articles about the effectiveness of artificial intelligence in cancer treatments for older adults. Methods : We conducted a systematic review by searching CINAHL, PsycINFO, and MEDLINE via EBSCO. We also conducted forward and backward hand searching for a comprehensive search. Eligible studies included a study population of older adults (60 and older) with cancer, used AI technology to treat cancer, and were published in a peer-reviewed journal in English. This study was registered on PROSPERO (CRD42024529270). Results : This systematic review identified seven articles focusing on lung, breast, and gastrointestinal cancers. They were predominantly conducted in the USA (42.9%), with others from India, China, and Germany. The measures of overall and progression-free survival, local control, and treatment plan concordance suggested that AI interventions were equally or less effective than standard care in treating older adult cancer patients. Conclusions: Despite promising initial findings, the utility of AI technologies in cancer treatment for older adults remains in its early stages, as further developments are necessary to enhance accuracy, consistency, and reliability for broader clinical use.
Keyphrases
- artificial intelligence
- systematic review
- papillary thyroid
- machine learning
- big data
- deep learning
- physical activity
- squamous cell
- randomized controlled trial
- childhood cancer
- lymph node metastasis
- squamous cell carcinoma
- meta analyses
- risk assessment
- young adults
- quality improvement
- climate change
- health insurance
- working memory
- combination therapy